In patients with diabetes and established diabetic retinopathy, treatment with GLP-1 receptor agonists is associated with increased risks of diabetic retinopathy progression compared with SGLT-2 inhibitors, according to a study in Diabetes, Obesity and Metabolism.
Researchers in Taiwan…
[ad_2]
Source link
